Tailoring a CRISPR/Cas-based Epigenome Editor for Programmable Chromatin Acylation and Decreased Cytotoxicity.
Goell J, Li J, Mahata B, Ma AJ, Kim S, Shah S, Shah S, Contreras M, Misra S, Reed D, Bedford GC, Escobar M, Hilton IB.
Goell J, et al. Among authors: bedford gc.
bioRxiv [Preprint]. 2024 Sep 22:2024.09.22.611000. doi: 10.1101/2024.09.22.611000.
bioRxiv. 2024.
PMID: 39345554
Free PMC article.
Preprint.